Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells. [electronic resource]
Producer: 20160118Description: e0124994 p. digitalISSN:- 1932-6203
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- metabolism
- Cell Line, Tumor
- Drug Synergism
- Flavonols -- pharmacology
- Humans
- Liver Neoplasms -- metabolism
- Organoplatinum Compounds -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.